Ningzi Z. Zang

Shenyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Bridging the gaps: the gut-lung axis and microbial metabolites in the pathogenesis and treatment of pulmonary fibrosis.

Bridging the gaps: the gut-lung axis and microbial metabolites in the pathogenesis and treatment of pulmonary fibrosis.

Journal: Frontiers in medicine
Published: February 26, 2026

Targeted Lung Denervation in COPD: Refining Phenotyping and Endpoints after AIRFLOW-3.

Targeted Lung Denervation in COPD: Refining Phenotyping and Endpoints after AIRFLOW-3.

Journal: American journal of respiratory and critical care medicine
Published: February 08, 2026

Viral Pathogens and Pulmonary Fibrosis: EMT-Driven Mechanisms and Insights From Traditional Chinese Medicine.

Viral Pathogens and Pulmonary Fibrosis: EMT-Driven Mechanisms and Insights From Traditional Chinese Medicine.

Journal: Reviews in medical virology
Published: December 29, 2025

Effectiveness and safety of four drainage methods for lung abscess: a Bayesian network meta-analysis and systematic review.

Effectiveness and safety of four drainage methods for lung abscess: a Bayesian network meta-analysis and systematic review.

Journal: Frontiers in medicine
Published: October 30, 2025

Research progress of complement system activation involved in idiopathic pulmonary fibrosis

Research progress of complement system activation involved in idiopathic pulmonary fibrosis

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: April 29, 2025

A Systematic Review of Mortality Risk Prediction Models for Idiopathic Pulmonary Fibrosis.

A Systematic Review of Mortality Risk Prediction Models for Idiopathic Pulmonary Fibrosis.

Journal: British journal of hospital medicine (London, England : 2005)
Published: April 23, 2025

Corrigendum to "The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway" [J. Ethnopharmacol. 322 (2024) 117507].

Corrigendum to "The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway" [J. Ethnopharmacol. 322 (2024) 117507].

Journal: Journal of ethnopharmacology
Published: April 20, 2025

Evidence map analysis of clinical studies on 42 commonly used oral Chinese patent medicines for the treatment of stable chronic obstructive pulmonary disease.

Evidence map analysis of clinical studies on 42 commonly used oral Chinese patent medicines for the treatment of stable chronic obstructive pulmonary disease.

Journal: Journal of ethnopharmacology
Published: February 27, 2025

Transcriptome Sequencing of lncRNAs, circRNAs, miRNAs, mRNAs, and Interaction Network Constructing in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Transcriptome Sequencing of lncRNAs, circRNAs, miRNAs, mRNAs, and Interaction Network Constructing in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Journal: Discovery medicine
Published: October 09, 2023

The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway.

The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway.

Journal: Journal of ethnopharmacology
Published: September 26, 2023

DNA damage resulting from human endocrine disrupting chemical exposure: Genotoxicity, detection and dietary phytochemical intervention.

DNA damage resulting from human endocrine disrupting chemical exposure: Genotoxicity, detection and dietary phytochemical intervention.

Journal: Chemosphere
Published: March 24, 2023
Showing 1-11 of 11

Last Updated: 09/26/2026